相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of VU0467485/AZ13713945: An M4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia
Michael R. Wood et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[C-11]methoxyphenyl) quinoline-2-carboxamide, for Imaging of Metabotropic Glutamate Receptor 2
Xiaofei Zhang et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Challenges in the development of an M4 PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogs
Michael R. Wood et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core
Michael R. Wood et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors
Craig W. Lindsley et al.
CHEMICAL REVIEWS (2016)
Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents
Michael Bubser et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Antipsychotic Drug-Like Effects of the Selective M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator VU0152100
Nellie E. Byun et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Discovery of a selective M4 positive allosteric modulator based on the 3-amino-thieno[2,3-b]pyridine-2-carboxamide scaffold: Development of ML253, a potent and brain penetrant compound that is active in a preclinical model of schizophrenia
Uyen Le et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Probing Structural Requirements of Positive Allosteric Modulators of the M4 Muscarinic Receptor
Tracey Huynh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptor
James M. Salovich et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties
Katie Leach et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Synthesis and Structure-Activity Relationships of Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor
J. Phillip Kennedy et al.
CHEMMEDCHEM (2009)
Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia
Anantha Shekhar et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Molecular imaging with PET
Simon M. Ametamey et al.
CHEMICAL REVIEWS (2008)
Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats
Ashley E. Brady et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Molecular imaging in drug development
Juergen K. Willmann et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
W. Y. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An allosteric potentiator of M-4 mAChR modulates hippocampal synaptic transmission
Jana K. Shirey et al.
NATURE CHEMICAL BIOLOGY (2008)
Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia
Elizabeth Scarr et al.
BIOLOGICAL PSYCHIATRY (2007)
Muscarinic receptors in the thalamus in progressive supranuclear palsy and other neurodegenerative disorders
Naomi M. Warren et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Towards a muscarinic hypothesis of schizophrenia
T. J. Raedler et al.
MOLECULAR PSYCHIATRY (2007)
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder
Paul Abrams et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Muscarinic acetylcholine receptors
Masaru Ishii et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Decreased density of muscarinic receptors in the superior temporal gyrus in schizophrenia
C Deng et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Investigation of M1/M4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder
Z Katerina et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease
MA Piggott et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2003)
Structure and activation of muscarinic acetylcholine receptors
EC Hulme et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients
E Mulugeta et al.
BRAIN RESEARCH (2003)
Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain
M Piggott et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2002)
Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: A study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment
JM Crook et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Decreased muscarinic receptor binding in subjects with schizophrenia: A study of the human hippocampal formation
JM Crook et al.
BIOLOGICAL PSYCHIATRY (2000)
Positron emission tomography provides molecular imaging of biological processes
ME Phelps
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
